Skip Navigation


Rheumatology Advance Access originally published online on March 20, 2008
Rheumatology 2008 47(5):733; doi:10.1093/rheumatology/ken096
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
47/5/733-a    most recent
ken096v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Shenker, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shenker, N.
Related Collections
Right arrow Education
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

LETTERS TO THE EDITOR

How much of what we do as doctors is ‘iatrocebo’?

N. Shenker

Department of Rheumatology, Addenbrooke's; Hospital, Cambridge, UK.

Correspondence to: N. Shenker, Department of Rheumatology, Addenbrooke's Hospital, Cambridge University Hospitals, Hills Road, Cambridge CB2 2QQ, UK. E-mail: mpxns@bath.ac.uk

The first 10% of the full text of this article appears below.

SIR, ‘Iatrocebo’ derives from the Greek ‘iatro’ meaning ‘physician, medicine or treatment’ and ‘placebo’ meaning ‘an inert substance given as a medicine for its suggestive effect’. Iatrocebo is defined as ‘an observed therapeutic effect erroneously . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?